TRxADE HEALTH
MEDS
#8480
Rank
$17.55 M
Marketcap
$12.48
Share price
-15.33%
Change (1 day)
41.98%
Change (1 year)

P/E ratio for TRxADE HEALTH (MEDS)

P/E ratio as of July 2024 (TTM): -2.98

According to TRxADE HEALTH's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.97778. At the end of 2022 the company had a P/E ratio of -1.26.

P/E ratio history for TRxADE HEALTH from 2014 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.26-69.73%
2021-4.17-96.85%
2020-132-446.2%
201938.2320.43%
20189.09-39.11%
201714.9-1683.09%
2016-0.9426-91.82%
2015-11.5104.14%
2014-5.64

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.